Efficacy Of Camrelizumab (Shr-1210) Plus Apatinib In Advanced Nsclc With Egfr MutationG. Gao,Y. Wang, S. Ren,Z. Liu, G. Chen, K. Gu,A. Zang,J. Zhao,R. Guo,J. He, X. Lin, Y. Pan, Z. Ma, Z. Wang,M. Fan,Y. Liu,S. Cang,X. Yang,Q. Wang, C. ZhouJOURNAL OF THORACIC ONCOLOGY（2021）引用 0|浏览9暂无评分关键词Immune checkpoint inhibitor, EGFR mutated NSCLC, VEGFR-TKIAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
